Catalyst Wire Dossier Catalyst Wire Dossier

BKM120

Buparlisib · Novartis
Drug timelines are a Plus or Pro feature.

31 regulatory and trial events tracked for BKM120, covering 2012-10-08 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck [Phase 1]

See pricing